BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Sabre//Sabre VObject 4.5.8//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:Europe/Zurich
X-LIC-LOCATION:Europe/Zurich
TZURL:http://tzurl.org/zoneinfo/Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:19810329T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:19961027T030000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:news1728@biomedizin.unibas.ch
DTSTAMP;TZID=Europe/Zurich:20260430T104925
DTSTART;TZID=Europe/Zurich:20260505T140000
SUMMARY:Guest Speaker: Ivana Jaric\, PhD - Institute of Laboratory Animal S
 cience at the University of Zurich
DESCRIPTION:Talk Summary:The historical exclusion of female subjects from p
 reclinical research is well documented\, and neuroscience has been among t
 he most resistant fields to change. For decades\, the assumption that ovar
 ian hormone fluctuations would introduce unwanted variability was used to 
 justify male-only study designs\, leaving a critical gap in our understand
 ing of female brain physiology and its contribution to psychiatric disorde
 r risk\, one that remains largely unaddressed.In this talk\, Dr. Jaric wil
 l discuss how the ovarian reproductive cycle\, and its natural or pharmaco
 logical disruption\, drives changes in hippocampal molecular and structura
 l plasticity in ways that may underlie female-specific vulnerability to an
 xiety and depression. She will further demonstrate how accounting for\, or
  ignoring\, ovarian hormone status critically affects reproducibility\, ge
 neralizability\, and translational relevance in sex-inclusive study design
 s. Finally\, Dr. Jaric will outline strategies for including both sexes an
 d accounting for endocrine state in preclinical rodent neuroscience resear
 ch\, to bring preclinical research closer to clinical practice and improve
  health outcomes for everyone.Short bio: Dr. Ivana Jaric is a Group Leader
  at the Institute of Laboratory Animal Science\, University of Zurich. Her
  research has two main focuses: developing evidence-based guidelines to ma
 ke rodent studies that include both sexes more translationally relevant\, 
 and investigating the epigenetic mechanisms underlying female-specific sus
 ceptibility to psychiatric disorders\, with a particular focus on the role
  of ovarian hormone status. 
X-ALT-DESC:<p><strong>Talk Summary:</strong><br />The historical exclusion 
 of female subjects from preclinical research is well documented\, and neur
 oscience has been among the most resistant fields to change. For decades\,
  the assumption that ovarian hormone fluctuations would introduce unwanted
  variability was used to justify male-only study designs\, leaving a criti
 cal gap in our understanding of female brain physiology and its contributi
 on to psychiatric disorder risk\, one that remains largely unaddressed.<br
  />In this talk\, Dr. Jaric will discuss how the ovarian reproductive cycl
 e\, and its natural or pharmacological disruption\, drives changes in hipp
 ocampal molecular and structural plasticity in ways that may underlie fema
 le-specific vulnerability to anxiety and depression. She will further demo
 nstrate how accounting for\, or ignoring\, ovarian hormone status critical
 ly affects reproducibility\, generalizability\, and translational relevanc
 e in sex-inclusive study designs. Finally\, Dr. Jaric will outline strateg
 ies for including both sexes and accounting for endocrine state in preclin
 ical rodent neuroscience research\, to bring preclinical research closer t
 o clinical practice and improve health outcomes for everyone.<br /><br /><
 strong>Short bio:</strong> Dr. Ivana Jaric is a Group Leader at the Instit
 ute of Laboratory Animal Science\, University of Zurich. Her research has 
 two main focuses: developing evidence-based guidelines to make rodent stud
 ies that include both sexes more translationally relevant\, and investigat
 ing the epigenetic mechanisms underlying female-specific susceptibility to
  psychiatric disorders\, with a particular focus on the role of ovarian ho
 rmone status.<br /><br />&nbsp\;</p>
DTEND;TZID=Europe/Zurich:20260505T150000
END:VEVENT
END:VCALENDAR
